RankingsPricing
  1. US-listed companies
  2. NeuBase Therapeutics, Inc.
  3. Raw

NeuBase Therapeutics, Inc.NBSE

Market cap
$1.41M
P/E ratio
SummaryFinancials
Back to summarized table
Sep 30,
2011		Sep 30,
2012		Sep 30,
2013		Sep 30,
2014		Sep 30,
2015		Sep 30,
2016		Sep 30,
2017		Sep 30,
2018		Sep 30,
2019		Sep 30,
2020		Sep 30,
2021		Sep 30,
2022
Cash and cash equivalents-----13-410325323
Prepaid insurance--------449,583521,617499,061319,699
Other prepaid expenses and current assets--------265,686294,64021
Total current assets691,7553513291313411335525
EQUIPMENT, net19,16443,11129,755104,425248,753198,63163,75715,763430,995122
Investment--------586,418323,557415,744-
Operating Lease, Right-of-Use Asset----------66
Security deposit---12,24312,24312,24312,243---253,615273,215
Other long-term assets----------160,423-
Total other assets--------1468,80776
TOTAL ASSETS146324629281213346433
Accounts payable--------1222
Accrued Liabilities, Current--------405,599555,88322
Insurance note payable-22,03714,05143,89948,06387,798106,38773,217122,919138,557148,385-
Operating lease liabilities----------382,576553,066
Finance lease liabilities----------107,632107,632
Total current liabilities61479,7375445724,9983-44
Long-term operating lease liability----------65
Long-term finance lease liability----------109,500-
TOTAL LIABILITIES61479,7375445724,998331010
Preferred Stock, Value, Issued55855850---------
Common Stock, Value, Issued3,9704,7261,9742,5253,0333,2075,6195,6471,7082,3153,2723,300
Additional paid-in capital223139701011091311323775123126
Accumulated deficit-21,628,748-21,628,748-21,628,748-43,313,548-58,511,413-84,277,611-108,088,607-121,325,507-27,000,199-43,558,602-68,967,903-102,744,353
Total stockholders' equity-4,781,75325274225231110315423
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY146324629281213346433